UT HEALTH EAST TEXAS JACKSONVILLE — History
CCN 450194 | 3-year financial timeline | COVID resilience: 45/100
🛡️ Public data only — no PHI permitted on this instance.
$47M
Latest Revenue (FY2022)
+1.8%
Revenue CAGR (3yr)
-3.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $45M | $40M | $47M | +16.4% | +1.8% |
| Operating Expenses | $44M | $44M | $49M | +9.9% | +5.6% |
| Operating Margin | 3.7% | -9.8% | -3.6% | +62.8% | +0.0% |
| Net Income | $2M | $-4M | $-2M | +56.7% | +0.0% |
| Licensed Beds | 35 | 38 | 38 | +0.0% | +4.2% |
| Total Patient Days | 5,230 | 6,799 | 4,905 | -27.9% | -3.2% |
| Medicare Day % | 23% | 24% | 21% | -10.2% | -2.6% |
| Medicaid Day % | 5% | 2% | 2% | +12.4% | -36.9% |
COVID Impact & Recovery
Resilience Score: 45/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +3.6% ($45M → $47M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.8%
This Hospital
+7.6%
State Avg
Latest Margin
-3.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $48M | -7.3% |
| FY2024 (proj) | $48M | -10.9% |
| FY2025 (proj) | $49M | -14.6% |